Ignite Creation Date:
2025-12-24 @ 10:29 PM
Ignite Modification Date:
2026-02-20 @ 4:14 PM
Study NCT ID:
NCT02485535
Status:
COMPLETED
Last Update Posted:
2021-05-13
First Post:
2015-06-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Selinexor in Treating Patients With Intermediate- and High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome After Transplant
Sponsor:
University of Chicago
Organization: